共 55 条
Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+Tregs
被引:108
作者:
Akimova, Tatiana
[2
]
Ge, Guanghui
[2
]
Golovina, Tatiana
[2
,3
]
Mikheeva, Tatiana
[2
,3
]
Wang, Liqing
[2
]
Riley, James L.
[2
,3
]
Hancock, Wayne W.
[1
,2
]
机构:
[1] Childrens Hosp Philadelphia, Div Transplant Immunol, Dept Pathol & Lab Med, Abramson Res Ctr 916B, Philadelphia, PA 19104 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
基金:
美国国家卫生研究院;
关键词:
Tregs;
HDAC;
Suppression;
Therapy;
FOXP3;
REGULATORY T-CELLS;
HISTONE-DEACETYLASE;
GENE-EXPRESSION;
FOXP3;
APOPTOSIS;
DIFFERENTIATE;
MORPHOGENESIS;
TRANSCRIPTION;
TRICHOSTATIN;
GENERATION;
D O I:
10.1016/j.clim.2010.04.018
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Histone/protein deacetylases (HDACs) decrease histone and protein acetylation, typically leading to suppression of gene transcription and modulation of various protein functions. We found significant differences in expression of HDAC before and after stimulation of human T regulatory (Treg) and T effector cells, suggesting the potential for future selective targeting of Tregs with HDAC inhibitors (HDACi). Use of various HDACi small molecules enhanced, by up to 4.5-fold (average 2-fold), the suppressive functions of both freshly isolated and expanded human Tregs, consistent with our previous murine data. HDACi use increased Treg expression of CTLA-4, a key negative regulator of immune response, and we found a direct and significant correlation between CTLA-4 expression and Treg suppression. Hence, HDACi compounds are promising pharmacologic tools to increase Treg suppressive functions, and this action may potentially be of use in patients with autoimmunity or post-transplantation. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:348 / 363
页数:16
相关论文